Investor Alert: LifeMD, Inc. Shareholders Must Act
Investors holding shares in LifeMD, Inc. (NASDAQ: LFMD) should consider reaching out to The Gross Law Firm before
October 25, 2025, to discuss their rights. This notice comes as part of an ongoing class action concerning alleged misleading statements made by the company during a critical reporting period.
Who Should Contact the Firm?
The Gross Law Firm is extending this invitation to all
shareholders who purchased LifeMD shares between
May 7, 2025, and
August 5, 2025. If you fit within this timeframe, experts recommend that you promptly get in touch to understand your potential eligibility for recovery.
Allegations Against LifeMD, Inc.
The complaint states that the defendants allegedly made significant misstatements about LifeMD's competitive standing, exaggerated future growth forecasts, and failed to adequately reflect the costs associated with acquiring new customers. In particular, these claims involve the company's performance in its
RexMD segment, which caused artificial inflation of the stock price. The assertions made by the company during this period are described as not just misleading but lacking any reasonable basis.
Specific Concerns Raised
1.
Overstated Competitive Position: The lawsuit claims that LifeMD significantly overstated its market standing.
2.
Unrealistic Revenue Projections: Allegations suggest that the firm raised its 2025 guidance without properly accounting for rising customer acquisition costs associated with popular medications for obesity, including products such as
Wegovy and
Zepbound.
3.
Misleading Statements: The firm issued statements that were, according to the lawsuit, materially false or lacked factual grounding, resulting in misleading information to investors about the company’s overall performance and prospects.
Registration and Next Steps for Shareholders
To participate in this class action lawsuit, shareholders are encouraged to register by following this link:
Register Here. Upon registration, participants will benefit from portfolio monitoring software that will keep them updated on the case's progress. There are no fees for participating in this lawsuit, and investors can opt for various levels of involvement.
The deadline for registration for those wishing to be considered for the role of lead plaintiff is
October 25, 2025. This does not mean that being a lead plaintiff is necessary for receiving any potential recovery, but it may enhance their impact in the case.
Why Choose The Gross Law Firm?
The Gross Law Firm is a well-respected name in class action litigation and actively protects the rights of investors jeopardized by corporate misconduct. Their mission focuses on ensuring companies maintain ethical conduct and transparency in their operations. They strive to secure recoveries for individuals who have sustained losses due to the wrongful actions of corporations, providing a safe harbor for victimized shareholders.
In conclusion, if you possess shares of LifeMD, Inc. acquired during the specified class period, immediate action is recommended. Contact The Gross Law Firm for expert guidance on how to proceed and best protect your investment. For any questions, potential participants can reach out via email at
[email protected] or call the firm at
(646) 453-8903.
Taking proactive steps now may equip investors with the necessary recourse against observed mismanagement and misrepresentation that may have harmed their interests.